Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, April 20, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Derivative

HOUSTON - Shares of Sarepta Therapeutics fell from $23.56 to $15.91 in a day when problems with its trial Duchenne muscular dystrophy drug eteplirsen were revealed, shareholders claim in Harris County Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...